Back to User profile » Dr Peishu Liu
Papers published by Dr Peishu Liu:
Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients
Bai G, Zhou Y, Rong Q, Qiao S, Mao H, Liu P
Journal of Inflammation Research 2023, 16:1227-1241
Published Date: 23 March 2023
Emodin Suppresses Proliferation, Migration and Invasion in Ovarian Cancer Cells by down Regulating ILK in vitro and in vivo [Retraction]
Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS
OncoTargets and Therapy 2022, 15:851-852
Published Date: 10 August 2022
Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients
Huang X, Wei X, Qiao S, Zhang X, Li R, Hu S, Mao H, Liu P
Cancer Management and Research 2021, 13:9015-9024
Published Date: 6 December 2021
Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis
Zhang X, Wei X, Bai G, Huang X, Hu S, Mao H, Liu P
Cancer Management and Research 2021, 13:8629-8646
Published Date: 16 November 2021
Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
Lin Q, Ma X, Hu S, Li R, Wei X, Han B, Ma Y, Liu P, Pang Y
Cancer Management and Research 2021, 13:1955-1965
Published Date: 25 February 2021
Oncogenic Role of NUPR1 in Ovarian Cancer
Yu J, Zhu H, Li R, Jiang Q, Luan W, Shi J, Liu P
OncoTargets and Therapy 2020, 13:12289-12300
Published Date: 30 November 2020
Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo
Zhang X, Lu T, Ma Y, Li R, Pang Y, Mao H, Liu P
OncoTargets and Therapy 2020, 13:5069-5082
Published Date: 8 June 2020
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer [Corrigendum]
Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P
OncoTargets and Therapy 2019, 12:9793-9794
Published Date: 15 November 2019
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P
OncoTargets and Therapy 2019, 12:8063-8074
Published Date: 3 October 2019
Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo
Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS
OncoTargets and Therapy 2017, 10:3579-3589
Published Date: 19 July 2017
Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
Li R, Dong T, Hu C, Lu J, Dai J, Liu P
OncoTargets and Therapy 2017, 10:1317-1325
Published Date: 28 February 2017